Eva Cesar-Cabrera

Malaga, AN 29010, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 46 publications

Vaping "Smoke-Free," but Not "Impact-Free": An Emerging Environmental Contradiction.

Vaping "Smoke-Free," but Not "Impact-Free": An Emerging Environmental Contradiction.

Journal: Archivos de bronconeumologia

Published: February 11, 2026

VEXAS Syndrome: A Newly Recognized Entity to Consider in Systemic Disease-Associated Interstitial Lung Disease.

VEXAS Syndrome: A Newly Recognized Entity to Consider in Systemic Disease-Associated Interstitial Lung Disease.

Journal: Open respiratory archives

Published: January 08, 2026

Use of New Tobacco and Nicotine Products as a Harm Reduction Strategy: A Critical Review of the Evidence.

Use of New Tobacco and Nicotine Products as a Harm Reduction Strategy: A Critical Review of the Evidence.

Journal: Open respiratory archives

Published: September 24, 2025

AI-Assistance Body Composition CT at T12 and T4 in Lung Cancer: Diagnosing Sarcopenia, and Its Correlation with Morphofunctional Assessment Techniques.

AI-Assistance Body Composition CT at T12 and T4 in Lung Cancer: Diagnosing Sarcopenia, and Its Correlation with Morphofunctional Assessment Techniques.

Journal: Cancers

Published: August 19, 2025

Cachexia Phenotyping Through Morphofunctional Assessment and Mitocondrial Biomarkers (GDF-15 and PGC-1α) in Idiopathic Pulmonary Fibrosis.

Cachexia Phenotyping Through Morphofunctional Assessment and Mitocondrial Biomarkers (GDF-15 and PGC-1α) in Idiopathic Pulmonary Fibrosis.

Journal: Nutrients

Published: July 16, 2025

Pulmonary Amyloidosis as a Differential Diagnosis in Interstitial Lung Diseases.

Pulmonary Amyloidosis as a Differential Diagnosis in Interstitial Lung Diseases.

Journal: Open respiratory archives

Published: June 25, 2025

Efficacy, Safety, and Economic Impact of Cytisinicline Maintenance Therapy in Patients Who Are Candidates for Smoking Cessation: Protocol for a Phase IV, Multicenter, Randomized, Open-Label, Controlled, Parallel Clinical Trial (CITISILONG Trial).

Efficacy, Safety, and Economic Impact of Cytisinicline Maintenance Therapy in Patients Who Are Candidates for Smoking Cessation: Protocol for a Phase IV, Multicenter, Randomized, Open-Label, Controlled, Parallel Clinical Trial (CITISILONG Trial).

Journal: JMIR research protocols

Published: May 04, 2025

Malnutrition, Sarcopenia, and Malnutrition Sarcopenia Syndrome in Idiopathic Pulmonary Fibrosis.

Malnutrition, Sarcopenia, and Malnutrition Sarcopenia Syndrome in Idiopathic Pulmonary Fibrosis.

Journal: Advances in respiratory medicine

Published: April 22, 2025

Real-world use of nintedanib for the treatment of interstitial lung disease with progressive pulmonary fibrosis.

Real-world use of nintedanib for the treatment of interstitial lung disease with progressive pulmonary fibrosis.

Journal: Medicina clinica

Published: April 01, 2025

The Nutritional Phenotyping of Idiopathic Pulmonary Fibrosis Through Morphofunctional Assessment: A Bicentric Cross-Sectional Case-Control Study.

The Nutritional Phenotyping of Idiopathic Pulmonary Fibrosis Through Morphofunctional Assessment: A Bicentric Cross-Sectional Case-Control Study.

Journal: Life (Basel, Switzerland)

Published: February 04, 2025

Inhaled Triple Therapy with Extrafine Single Inhaler Versus Multiple Devices in Chronic Obstructive Pulmonary Disease (TRIPOLI): A Post-Authorization Retrospective Study.

Inhaled Triple Therapy with Extrafine Single Inhaler Versus Multiple Devices in Chronic Obstructive Pulmonary Disease (TRIPOLI): A Post-Authorization Retrospective Study.

Journal: International journal of chronic obstructive pulmonary disease

Published: January 08, 2025

Comparison of the Determinants of the "Chronic Obstructive Pulmonary Disease Assessment Test" (CAT) and the "Asthma Control Test" (ACT) in Patients with Asthma-COPD Overlap.

Comparison of the Determinants of the "Chronic Obstructive Pulmonary Disease Assessment Test" (CAT) and the "Asthma Control Test" (ACT) in Patients with Asthma-COPD Overlap.

Journal: Journal of clinical medicine

Published: September 02, 2024

Showing 1-12 of 46

Last Updated: 09/26/2026